Gossamer Bio ( GOSS ) Reports Q3 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) delivered earnings and revenue surprises of 22.22% and 109.97%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
| Ticker |
Sentiment |
Impact |
|
GOSS
|
Neutral
|
41 %
|
|
CARA
|
Neutral
|
21 %
|
